BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7609740)

  • 1. [Pharmacokinetics of itraconazole].
    Cauwenbergh G
    Mycoses; 1994; 37 Suppl 2():27-33. PubMed ID: 7609740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for opportunistic fungal infections: past, present and future.
    Stevens DA
    Indian J Cancer; 1995 Mar; 32(1):1-9. PubMed ID: 7558104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itraconazole: managing mycotic complications in immunocompromised patients.
    Graybill JR
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):58-63. PubMed ID: 9671333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The place for itraconazole in treatment.
    Maertens J; Boogaerts M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itraconazole: pharmacokinetics and indications.
    Negroni R; Arechavala AI
    Arch Med Res; 1993; 24(4):387-93. PubMed ID: 8118163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of invasive aspergillosis with itraconazole: our own experiences and review of the literature].
    Kreisel W
    Mycoses; 1994; 37 Suppl 2():42-51. PubMed ID: 7609743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of fungal infections in patients infected with the human immunodeficiency virus.
    Sugar AM
    Pharmacotherapy; 1990; 10(6 ( Pt 3)):154S-158S. PubMed ID: 2075115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for managing systemic fungal infection and the place of itraconazole.
    Potter M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i49-i54. PubMed ID: 16120634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Itraconazole in systemic fungal infections. Clinical profile and future trends].
    Fernández Fernández A; Esteban Montero S
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():66-70. PubMed ID: 9441309
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view.
    De Rosso JQ; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():46-52. PubMed ID: 10492666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scopulariopsis brevicaulis infection in a patient with acute myeloid leukemia.
    Ng KP; Soo-Hoo TS; Na SL; Gan GG; Sangkar JV; Teh AK
    Med J Malaysia; 2003 Oct; 58(4):608-12. PubMed ID: 15190640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of systemic candidiasis].
    Meunier F
    Mycoses; 1994; 37 Suppl 2():52-5. PubMed ID: 7609744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making sense of itraconazole pharmacokinetics.
    Prentice AG; Glasmacher A
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i17-i22. PubMed ID: 16120630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria.
    Stevens DA; Lee JY
    Arch Intern Med; 1997 Sep; 157(16):1857-62. PubMed ID: 9290545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    McKinsey DS; Wheat LJ; Cloud GA; Pierce M; Black JR; Bamberger DM; Goldman M; Thomas CJ; Gutsch HM; Moskovitz B; Dismukes WE; Kauffman CA
    Clin Infect Dis; 1999 May; 28(5):1049-56. PubMed ID: 10452633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of itraconazole.
    De Beule K; Van Gestel J
    Drugs; 2001; 61 Suppl 1():27-37. PubMed ID: 11219548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Level of evidence for therapeutic drug monitoring of itraconazole].
    Charles M; Le Guellec C; Richard D; Libert F;
    Therapie; 2011; 66(2):103-8. PubMed ID: 21635856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled clinical trial of itraconazole for prevention of fungal infections secondary to chemotherapy.
    Wang CY; Wu BY; Guo KY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):389-90. PubMed ID: 12697487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
    Caillot D; Bassaris H; McGeer A; Arthur C; Prentice HG; Seifert W; De Beule K
    Clin Infect Dis; 2001 Oct; 33(8):e83-90. PubMed ID: 11550120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America.
    Kauffman CA; Hajjeh R; Chapman SW
    Clin Infect Dis; 2000 Apr; 30(4):684-7. PubMed ID: 10770730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.